Osmopharm S.A. is a Swiss pharmaceutical company founded in 1994 in Southern Switzerland (near Lugano), specializing in modified release oral drug delivery systems. It is one of the worldwide leaders in contract manufacturing of modified release oral solid dosage forms. The facility covers approximately 6,000 sqm and serves over 100 pharmaceutical customers. Authorized by Swissmedic under current GMP requirements.
Modified release oral solid dosage forms using advanced galenic technologies including pellet-based systems, coating, extrusion-spheronization, ion-exchange resinates. Services cover bulk manufacturing, capsule filling, tabletting, blistering, and final consumer packaging.
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.